Unlike other tumor suppressor genes, over 70% of cancer-associated TP53 mutations are missense mutations mainly located in the DNA-binding domain (3), causing single amino acid substitutions and consequently DNA-contact or structural mutations (4). This evidence concerns the gene TP53 and cancer.